Cleared Traditional

K834215 - MINI-1 TRANSCUTANEOUS ELEC-NERVE STIM

K834215 is an FDA 510(k) clearance for MINI-1 TRANSCUTANEOUS ELEC-NERVE STIM, manufactured by Th Charters, Inc.. The device is a Class 2 Neurology device with product code GZJ cleared through the Traditional 510(k) pathway after a 29-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jan 1984
Decision
29d
Days
Class 2
Risk

K834215 is an FDA 510(k) clearance for the MINI-1 TRANSCUTANEOUS ELEC-NERVE STIM. Classified as Stimulator, Nerve, Transcutaneous, For Pain Relief (product code GZJ), Class II - Special Controls.

Submitted by Th Charters, Inc. (Walker, US). The FDA issued a Cleared decision on January 3, 1984 after a review of 29 days - a notably fast clearance cycle.

This device falls under the Neurology FDA review panel, regulated under 21 CFR 882.5890 - the FDA neurology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K834215

510(k) Number K834215 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 05, 1983
Decision Date January 03, 1984
Days to Decision 29 days
Submission Type Traditional
Review Panel Neurology (NE)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
120d faster than avg
Panel avg: 149d · This submission: 29d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

GZJ Device Classification - Class 2, Special Controls

Product Code GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 882.5890
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Neurology devices follow this clearance model.

Regulatory Peers - GZJ Stimulator, Nerve, Transcutaneous, For Pain Relief

All 605
Devices cleared under the same product code (GZJ) and FDA review panel - the closest regulatory comparables to K834215.
MEDAID DUAL CHANNEL TENS
K834334 · Par Medex , Ltd. · Feb 1984
HEALTH-UP
K840040 · Kung-Ho International, Inc. · Feb 1984
NEUROTRON 100
K833086 · Neutro-Tronics · Jan 1984
TRANSCUTANEOUS ELECTRONIC NERVE STIMU
K831938 · Joseph M. Piocentile · Dec 1983
POINTER F-3
K833037 · Petra Intl. Co. · Nov 1983
NEUROFLAX, EPK
K831990 · Franks Electronics · Nov 1983